World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
22639
World Ranking
3287
National Ranking
137

Carl G. Feng publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carl G. Feng sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 123 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carl G. Feng D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carl G. Feng sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carl G. Feng is affiliated with the University of Sydney in Australia. Their research spans several interconnected areas within immunology, microbiology, and medicine, with a particular focus on tuberculosis and immune system functionality.

The main fields of study covered by their work include:

  • Immunology and Microbiology
  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broad fields, subfields of specialization include:

  • Immunology
  • Infectious Diseases
  • Molecular Biology
  • Epidemiology
  • Oncology

The primary topics addressed in their research are:

  • Tuberculosis Research and Epidemiology
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Immune cells in cancer
  • Immune Response and Inflammation
  • Single-cell and spatial transcriptomics
  • Immune responses and vaccinations

Notable recent publications include:

  • "Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis," 2020, EBioMedicine
  • "Regulation of T Helper Cell Fate by TCR Signal Strength," 2020, Frontiers in Immunology
  • "A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection," 2021, npj Vaccines
  • "Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis," 2020, npj Vaccines
  • "Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis," 2023, The Journal of Experimental Medicine

Frequent co-authors contributing to their research efforts include:

  • Xinchun Chen
  • Warwick J. Britton
  • Yi Cai
  • Nayan D. Bhattacharyya
  • Claudio Counoupas

Most of their work has been published in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Microbiology
  • EBioMedicine
  • Frontiers in Immunology
  • npj Vaccines

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • A Critical Role for IL-21 in Regulating Immunoglobulin Production

    Katsutoshi Ozaki;Rosanne Spolski;Carl G. Feng;Chen-Feng Qi

  • TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis

    André Báfica;Charles A Scanga;Carl G. Feng;Cynthia Leifer

  • Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection.

    Dragana Jankovic;Marika C. Kullberg;Carl G. Feng;Romina S. Goldszmid

  • IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis

    Marika C. Kullberg;Dragana Jankovic;Carl G. Feng;Sophie Hue

  • Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection

    Katrin D. Mayer-Barber;Bruno B. Andrade;Daniel L. Barber;Sara Hieny

  • Differential Protective Efficacy of DNA Vaccines Expressing Secreted Proteins of Mycobacterium tuberculosis

    Arun T. Kamath;Carl G. Feng;Murdo Macdonald;Helen Briscoe;Helen Briscoe

  • Macrophage and T Cell Dynamics During the Development and Disintegration of Mycobacterial Granulomas

    Jackson G. Egen;Antonio Gigliotti Rothfuchs;Carl G. Feng;Nathalie Winter

  • The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1)

    Svenja Steinfelder;John F. Andersen;Jennifer L. Cannons;Carl G. Feng

  • P47 GTPASES: REGULATORS OF IMMUNITY TO INTRACELLULAR PATHOGENS

    Gregory A. Taylor;Carl G. Feng;Alan Sher

  • CD4 T Cells Promote Rather Than Control Tuberculosis in the Absence of PD-1-mediated Inhibition

    Daniel L. Barber;Katrin D. Mayer-Barber;Carl G. Feng;Arlene H. Sharpe

  • Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population

    Lis R.V. Antonelli;Antonio Gigliotti Rothfuchs;Ricardo Gonçalves;Ester Roffê

  • NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis

    Carl G. Feng;Mallika Kaviratne;Antonio Gigliotti Rothfuchs;Allen Cheever

  • Mycobacterium tuberculosis Triggers Host Type I IFN Signaling To Regulate IL-1β Production in Human Macrophages

    Aleksey Novikov;Marco Cardone;Robert Thompson;Kevin Shenderov

  • Intravital Imaging Reveals Limited Antigen Presentation and T Cell Effector Function in Mycobacterial Granulomas

    Jackson G. Egen;Antonio Gigliotti Rothfuchs;Carl G. Feng;Marcus A. Horwitz

  • Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by toll-like receptor 2 (TLR2)- and TLR4-deficient animals

    Carl G. Feng;Charles A. Scanga;Carmen M. Collazo-Custodio;Allen W. Cheever

  • Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity

    Rachael M. Reiman;Robert W. Thompson;Carl G. Feng;Danielle Hari

  • Dectin-1 Interaction with Mycobacterium tuberculosis Leads to Enhanced IL-12p40 Production by Splenic Dendritic Cells

    Antonio Gigliotti Rothfuchs;Andre Bafica;Carl G. Feng;Jackson G. Egen

  • MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression.

    Charles A. Scanga;Andre Bafica;Carl G. Feng;Allen W. Cheever

  • Increase in Gamma Interferon-Secreting CD8+, as Well as CD4+, T Cells in Lungs following Aerosol Infection with Mycobacterium tuberculosis

    Carl G. Feng;Andrew G. D. Bean;Helena Hooi;Helen Briscoe;Helen Briscoe

  • are the major source of host-protective regulatory IL-10 during intracellular protozoan infection

    Dragana Jankovic;Marika C. Kullberg;Carl G. Feng;Romina S. Goldszmid

Frequent Co-Authors

Alan Sher
Alan Sher National Institute of Allergy and Infectious Diseases
Warwick J. Britton
Warwick J. Britton University of Sydney
Gregory A. Taylor
Gregory A. Taylor Duke University
Dragana Jankovic
Dragana Jankovic National Institute of Allergy and Infectious Diseases
Allen W. Cheever
Allen W. Cheever National Institutes of Health
Sara Hieny
Sara Hieny National Institute of Allergy and Infectious Diseases
Caroline Demangel
Caroline Demangel Institut Pasteur
Patricia Caspar
Patricia Caspar National Institute of Allergy and Infectious Diseases
Thomas A. Wynn
Thomas A. Wynn Pfizer (United States)
Christopher M. Sassetti
Christopher M. Sassetti University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students consider accelerated pathways to enter the field more quickly. Programs such as accelerated NP programs online offer a fast track to becoming a nurse practitioner, combining advanced immunology knowledge with clinical practice.

If you’re starting without a nursing background, there are specialized options like online nursing programs for non nurses. These programs provide foundational nursing education along with crucial immunology principles, helping students transition smoothly into healthcare roles.

For those seeking a quicker route to nursing credentials, 12-month accelerated nursing programs are a popular choice. Resources like 12-month accelerated nursing programs highlight options that balance speed and quality of instruction, ideal for motivated learners aiming to work in immunology-related settings.

Additionally, exploring programs with more accessible admission criteria can be beneficial. Programs such as those listed under easy admission LPN programs provide practical entry points into patient care, offering hands-on experience in immunology-focused environments.

Best Scientists Citing Carl G. Feng

Trending Scientists

Recently Published Articles